RT @DaleYuzuki: Eggermont: Prembro (anti-PD-1) avoids PD1-PDL1/2 bidning (that suppresses CTL activity) OS curve from '17 https://t.co/tmzg…
919 followers
5,745 followers
Eggermont: Prembro (anti-PD-1) avoids PD1-PDL1/2 bidning (that suppresses CTL activity) OS curve from '17 https://t.co/tmzgPhHgxw #AACR18
216 followers
RT @OncologyAdvance: The impact of novel therapies on survival for advanced metastatic #melanoma https://t.co/BaDTasXZ12 https://t.co/KS4tc…
3,344 followers
RT @OncologyAdvance: The impact of novel therapies on survival for advanced metastatic #melanoma https://t.co/BaDTasXZ12 https://t.co/KS4tc…